pyrazines has been researched along with ganciclovir in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boothpur, R; Brennan, DC; Torrence, S | 1 |
| Besa, E; Bray, P; Caro, J; Dulau Florea, A; Mahipal, A; Sbenghe, MM | 1 |
2 other study(ies) available for pyrazines and ganciclovir
| Article | Year |
|---|---|
Bortezomib does not reduce ABO-isoagglutinin titers and may not be useful for ABO-incompatible transplant desensitization.
Topics: ABO Blood-Group System; Antiviral Agents; Blood Group Incompatibility; Boronic Acids; Bortezomib; Cytomegalovirus Infections; Doxorubicin; Ganciclovir; Hemagglutinins; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Multiple Myeloma; Protease Inhibitors; Pyrazines; Valganciclovir | 2009 |
HHV-8-associated multicentric Castleman's disease in HIV-negative patient: a novel therapy for an orphan disease.
Topics: Adult; Boronic Acids; Bortezomib; Castleman Disease; Ganciclovir; Herpesviridae Infections; Herpesvirus 8, Human; HIV; Humans; Male; Pyrazines; Rare Diseases | 2012 |